Supernus Pharmaceuticals, Inc.
Modified release preparations containing oxcarbazepine and derivatives thereof

Last updated:

Abstract:

Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.

Status:
Grant
Type:

Utility

Filling date:

23 Apr 2021

Issue date:

9 Nov 2021